Cases 1 - 10 of 247
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amgen Inc. v. Amneal Pharmaceuticals et al
as 1:2016cv00853
Defendant:
Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc. and others
Plaintiff:
Amgen Inc.
3Rd Party Defendant:
Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant:
Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant:
Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff:
Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARMACEUTICALS, INC. et al
as 2:2015cv08180
Defendant:
MYLAN PHARMACEUTICALS, INC., MYLAN INC., ACTAVIS LLC and others
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC., PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC. and others
Cause Of Action: 35 U.S.C. § 271
MERCK SHARP & DOHME CORP. et al v. ACTAVIS LABORATORIES FL, INC.
as 2:2020cv00534
Defendant:
TEVA PHARMACEUTICALS USA, INC., ACTAVIS LABORATORIES FL, INC. and ACTAVIS PHARMA, INC.
Plaintiff:
MSD INVESTMENT HOLDINGS (IRELAND), OPTIMER PHARMACEUTICALS LLC, MERCK SHARP & DOHME CORP. and others
Cause Of Action: 15 U.S.C. § 1126
MERK SHARP & DOHME CORP. et al v. ACTAVIS LABORATORIES FL, INC. et al
as 2:2020cv00533
Defendant:
TEVA PHARMACEUTICALS USA, INC., ACTAVIS LABORATORIES FL, INC. and ACTAVIS PHARMA, INC.
Plaintiff:
MSD INVESTMENT HOLDINGS (IRELAND), OPTIMER PHARMACEUTICALS LLC, MSD INTERNATIONAL GMBH and others
Cause Of Action: 15 U.S.C. § 1126
Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc.
as 1:2018cv00758
Defendant:
Actavis Laboratories UT, Inc.
Plaintiff:
Noven Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv01832
Defendant:
Teva Pharmaceuticals USA, Inc., Actavis LLC and Teva Pharmaceutical Industries Ltd.
Plaintiff:
CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
